The abstract mentions that HCN1, HCN2, and HCN4 all play pathogenic roles in epilepsy but doesn't explain their distinct contributions. This mechanistic gap limits the development of isoform-specific therapeutic strategies for epilepsy treatment. Gap type: unexplained_observation Source paper: Cardiac and neuronal HCN channelopathies. (2020, Pflugers Arch, PMID:32424620)
Landscape Summary: How do different HCN isoforms (HCN1, HCN2, HCN4) contribute differentially to epilepsy pathogenesis? is a 0.77 priority gap in neurological-disorders. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How do different HCN isoforms (HCN1, HCN2, HCN4) contribute differentially to epilepsy pathogenesis? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: